Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-012241
Filing Date
2013-07-29
Accepted
2013-07-29 16:52:52
Documents
1
Period of Report
2013-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6054
  Complete submission text file 0001179110-13-012241.txt   7555
Mailing Address CO/CYTOGEN CORPORATION 600 COLLEGE RD PRINCETON NJ 19044
Business Address
MCKEARN THOMAS J (Reporting) CIK: 0001022849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 13993060

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations